
|Articles|October 24, 2012
FDA advises patient notification
The FDA advises health-care professionals to follow up with patients for whom they administered an injectable product purchased from or produced by NECC.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ophthalmic innovation by the decades: The 2000s
2
EyePoint Pharmaceuticals details phase 3 program evaluating vorolanib intravitreal insert (DURAVYU) for DME
3
The Residency Report: Social media and the modern ophthalmologist
4
FDA approves Rayner’s RayOne EMV Toric intraocular lens
5